Evidence map›Paper›PMID 15767414›Full record

ArticleJournal of virology2005

Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.

Banson Barugahare, Chris Baker, Okumu K'Aluoch, Richard Donovan, Mohamed Elrefaei, Mark Eggena, Norman Jones, Steven Mutalya, Cissy Kityo, Peter Mugyenyi and 1 more

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV viral diversity and escape from cellular immunity.Current infectious disease reports · 2007
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Banson BarugahareJoint Clinical Research Centre, Kampala, Uganda.
Chris Baker
Okumu K'Aluoch
Richard Donovan
Mohamed Elrefaei
Mark Eggena
Norman Jones
Steven Mutalya
Cissy Kityo
Peter Mugyenyi
Huyen Cao

Funding

HIV-1 Fusion CoreceptorsR01AI043885 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 1998 to 2008
$1.8M
HIV-1 Fusion CoreceptorsR21AI043885 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER · 2003 to 2003
$299k
NIAID NIH HHS AI43885NIAID NIH HHS R01 AI043885NIAID NIH HHS R21 AI043885
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) or AIDS is currently the leading cause of death in Uganda, with at least three HIV clades (subtypes) accounting for most new infections. Whether an effective vaccine formulated on viruses from a single clade will be able to protect against infection from other local clades remains unresolved. We examined the T-cell immune responses from a cohort of HIV-seropositive individuals in Uganda with predominantly clade A and D infections. Surprisingly, we observed similar frequencies of cross-clade T-cell responses to the gag, env, and nef regions. Our data suggest that the level of viral sequence variability between distinct HIV strains does not predict the degree of cross-clade responses. High sequence homologies were also observed between consensus peptides and sequences from viral isolates, supporting the use of consensus amino acid sequences to identify immunogenic regions in studies of large populations.

Indexed as

AdultCell ProliferationConsensus SequenceConserved SequenceCross ReactionsEpitope MappingEpitopesFemaleGene Products, envGene Products, gagGene Products, nefHIV-1HIV AntigensHIV InfectionsHumansInterferon-gammaEpitopesGene Products, envGene Products, gagGene Products, nefHIV AntigensInterferon-gammanef Gene Products, Human Immunodeficiency Virus

Identifiers

PMID15767414
PMCPMC1061582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.